- Formula of Miller et al for Normal Range Westergren ESR for Age and Gender
- Correction of ESR to a Hematocrit of 40%
- Factors That Can Affect the Erythrocyte Sedimentation Rate (ESR)
- Simplified Method of Pawlotsky et al for the Sigma ESR
- Nomogram of Manely for Correcting the Erythrocyte Sedimentation Rate (ESR) Based on Room Temperature
- Mentzer Formula
- England-Fraser Formula
- Shine-Lal Formula
- M / H Ratio
- RDW * HDW
- MCV / MCH Ratio
- MCH / RBC Ratio
- RDW / RBC Ratio
- Green and King Formula
- Discriminant Functions of Eldibany et al for Diagnosing Microcytic Anemias
- Calculating the Total Iron Replacement Dose in Iron Deficiency Anemia
- Criteria for the Primary Defective Iron-Reutilization Syndrome
- Amount of Iron Lost Through a Known Blood Loss with an Estimate for the Replacement Dose
- Clinical Response to Adequate Iron Replacement
- Indications for Intravenous Iron Replacement with Iron Dextran
- Equation of Witte et al for Predicting Iron Deficiency from Serum Ferritin and the Erythrocyte Sedimentation Rate (ESR)
- Algorithm of Mulherin et al for the Diagnosis of Iron Deficiency Anemia vs Anemia of Chronic Disease in a Patient with Rheumatoid Arthritis
- Use of Soluble Serum Transferrin Receptor to Evaluate an Anemic Patient with a Low Serum Iron Level
- Stages of Iron Depletion and Deficiency
- Clinical Findings in Iron Deficiency Not Associated with Anemia
- Scoring System of Casanova et al for Identifying Iron Deficiency Anemia in a Pregnant Woman
- Staging Iron Deficiency Using the Concentration of Zinc Protoporphyrin
- Protocol of Heming et al for Identifying Iron Deficiency Anemia in a Critically Ill Patient
- Hereditary Atransferrinemia with Iron Overload and Microcytic Anemia
- Iron-Refractory Iron Deficiency Anemia (IRIDA) Associated with a Mutation in TMPRSS6
- Corrected Absolute Reticulocyte Count from RBC Count
- Corrected Reticulocyte Count for Hct (Reticulocyte Index)
- Reticulocyte Production Index (RPI)
- Reticulocyte Production Index by a Single Equation
- Reticulocyte Hemoglobin Content
- RBC-to-Reticulocyte Hemoglobin Concentration Ratio
- Wintrobe's Formula for Red Cell Indices (MCV, MCH, MCHC)
- Estimating Hematocrit from Hematologic Parameters
- Red Cell Distribution Width (RDW)
- Hemoglobin Correction for Altitude
- Hematocrit to Hemoglobin Ratio and Hemoconcentration
- Causes of a Dimorphic Red Blood Cell Volume Histogram
- Osmotic Fragility
- Thermal Fragility and Pyropoikilocytosis
- Red Blood Cell Production at Steady State
- Grading Severe Aplastic Anemia
- Criteria of Kwong et al for Response to Therapy for a Patient with Pure Red Cell Aplasia
- Aplastic Anemia Following Infectious Mononucleosis (Epstein-Barr Virus, EBV)
- Aplastic Anemia Following an Episode of Viral Hepatitis
- Hypoplastic or Aplastic Anemia Associated with a Thymoma
- Clinical Features of Pure Red Cell Aplasia Associated with Epoetin Therapy
- Pure Red Cell Aplasia Associated with Pregnancy
- Factors of Yoshida et al Predicting Response of a Child with Aplastic Anemia to Immunosuppressive Therapy
- Criteria of the Japanese Childhood Aplastic Anemia Study Group for Response to Therapy
- Inherited Bone Marrow Failure Syndromes
- Dyskeratosis Congenita (DC)
- Myelophthisis
- Trauma-Associated Bone Marrow Failure
- Aplastic Anemia and Hairy Cell Leukemia (HCL)
- Aplastic Anemia vs Hypoplastic Myelodysplasia
- Drugs and Chemicals Associated with Aplastic Anemia
- Distinguishing Aplastic Anemia from Disseminated Mycobacteriosis
- Hemoglobin Electropheresis
- Estimating the P50 for Hemoglobin from a Venous Blood Sample
- Causes of an Elevated Hemoglobin F
- Causes of an Elevated Hemoglobin A2
- Causes of an Decreased Hemoglobin A2
- Differential Diagnosis of a Markedly Elevated Level of Hemoglobin A2
- Upper Limit of Hemoglobin F During Infancy
- Acute Splenic Sequestration in Patients with Sickle Cell Disease
- Model of Miller et al for Predicting the Risk of Severe Complications in a Child with Sickle Cell Disease
- Risk Factors of Platt et al for Early Death in Patients with Sickle Cell Disease
- Clinical Danger Signs for Acute Complications in a Patient with Sickle Cell Disease
- Estimating the Pain Rate in a Patient with Sickle Cell Disease Using the Equation of Platt et al
- 1999 Indications of Steinberg for Starting and Continuing Hydroxyurea Therapy in a Patient with Sickle Cell Disease
- Risk Factors Associated with Mortality in Patients from the Multicenter Study of Hydroxyurea in Sickle Cell Anemia
- Criteria of Galloway and Harwood-Nuss for Admitting a Patient with a Sickle Cell Crisis
- Features of Kato et al for the Syndrome of Hemolysis-Associated Endothelial Dysfunction in Sickle Cell Disease
- Factors Identified by Ware et al Predicting the Fetal Hemoglobin Response to Hydroxyurea Therapy in Children with Sickle Cell Anemia
- Predictors of Adverse Outcome in a Pediatric Patient with Sickle Cell Anemia from the Cooperative Study of Sickle Cell Disease
- Factors of Ballas and Lusardi for Hospital Readmission in an Adult with Acute Sickle Cell Pain
- Severity Classification of Painful Crises in Sickle Cell Disease
- Clinical Features of Berger et al for Distinguishing a Vaso-Occlusive Crisis from Osteomyelitis in a Child with Sickle Cell Disease
- Severity Index of Wali et al for a Child with Sickle Cell Disease (SCD)
- Predictors of Wali et al for Preservation of Splenic Function in a Child with Sickle Cell Disease
- The Various Types of Sickle Cell Crises (Acute Exacerbations)
- Index of van den Tweel et al for Severity of Sickle Cell Disease (SCD) in a Pediatric Patient
- Clinical Severity Rating for Categorizing Events in a Patient with Sickle Cell Anemia
- Risk Factors of Lorch et al for Excess Mortality in an Adult with Sickle Cell Disease
- Intensive Care Unit Anemia Score of Milbrandt et al
- Screening for Hereditary Spherocytosis With MCHC and RDW
- Clinical and Laboratory Findings of Hereditary Pyropoikilocytosis
- Platelet Count Estimate from Peripheral Blood Smear
- Manual Platelet Counts Using a Hemacytometer
- EDTA-dependent Pseudothrombocytopenia and Platelet Satellitism
- Residual Platelet Distribution Width in Thrombocytosis
- Using the RBC to Platelet Ratio Method for Measuring the Platelet Count
- Criteria of Gulati et al for Grading Platelet Satellitism
- Causes of Secondary (Reactive) Thrombocytosis
- Pseudothrombocytosis Associated with Cryoglobulinemia
- Megakaryocytes in the Peripheral Blood
- White Cell Count Estimate from Peripheral Blood Smear
- Correction of WBC for Nucleated Red Blood Cells
- In Vitro Pseudoleukopenia
- Absolute Phagocyte Count (APC)
- Pseudoleukocytosis
- Monocyte-to-Lymphocyte Ratio in Granulomatous Diseases
- Necrobiotic Granuloma
- Leukocyte Alkaline Phosphatase Score
- FAB Classification of the Myelodysplastic Syndromes
- Bournemouth Score of Mufti et al and Prognosis for the Myelodysplastic Syndromes
- Score of Sanz et al and Prognosis for the Myelodysplastic Syndromes
- Score of Goasguen et al and Prognosis for the Myelodysplastic Syndromes
- Score of Varela et al and Prognosis for the Myelodysplastic Syndromes
- Additional Factors Affecting the Prognosis for the Myelodysplastic Syndromes
- A Prognostic Score for Myelodysplasia Based on Bone Marrow Histopathology (Hannover Score)
- Dusseldorf Score and Prognosis in Primary Myelodysplastic Syndromes
- International Prognostic Scoring System (IPSS) to Predict Survival in the Myelodysplastic Syndromes
- FPC Prognostic Score of Passmore et al for Pediatric Myelodysplasia
- Pavia Score and Prognosis for the Myelodysplastic Syndrome
- Prognostic Score of Onida et al for Patients with Chronic Myelomonocytic Leukemia (M.D. Anderson Prognostic Score, MDAPS)
- Features of the 5q- Myelodysplastic Syndrome
- Features of Refractory Cytopenia with Multilineage Dysplasia (RCMD)
- Features of Refractory Anemia with Excess Blasts (RAEB) in the WHO Classification for Myelodysplasia
- Features of Chronic Myelomonocytic Leukemia (CMML) in the WHO Classification of Myelodysplasia
- Features of Juvenile Myelomonocytic Leukemia (JMML) in the WHO Classification of Myelodysplasia
- Prognostic Factors for Patients with Juvenile Myelomonocytic Leukemia (JMML)
- Prognostic System of Matsuda et al for Patients with Refractory Anemia
- Discriminant Score of Castro-Malaspina et al for Children with Chronic Myelomonocytic Leukemia
- Prognostic Index for Cytogenetics (PI Score) of Pfeilstocker et al for a Patient with Myelodysplasia
- Modified Bournemouth Score of Worsley et al for Patients with Chronic Myelomonocytic Leukemia
- The Lausanne-Bournemouth (LB) Score of Parlier et al for a Patient with Primary Myelodysplastic Syndrome
- The Lille Scoring Score of Morel et al for a Patient with a Primary Myelodysplastic Syndrome
- The Four Parameter Dysplasia Index (DI) of Tassin et al for Survival in a Patient with a Myelodysplastic Syndrome (Liege Score)
- The Granulation Score (G-Score) for Neutrophils of Widell et al
- The Percentage of Pelgeroid Polymorphs (ppp) of Widell et al
- Bone Marrow Dysplasia Score of Widell et al in a Patient with Myelodysplasia
- Hematologic and Cytogenetic Score of Toyama et al for a Patient with Myelodysplasia
- Risk Score of Gatto et al for a Patient with the Myelodysplastic Syndrome (MDS)
- Hematologic Features of a Myelodysplastic-like Syndrome in Copper Deficiency
- Criteria of Cheson et al for Hematologic Improvement Following Therapy for a Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
- Criteria of Cheson et al for Disease Progression or Relapse After Hematologic Improvement Following Therapy for Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
- Criteria of Cheson et al for Complete or Partial Remission After Therapy for Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
- Prognostic Model of Ribera et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
- Prognostic Groups of Tennant et al for Patients with Myelodysplasia
- Criteria of Cheson et al for Cytogenetic Response Following Therapy for a Myelodysplastic Syndrome (International Working Group to Standardize Response Criteria)
- Recommendations of Estey for Therapy of Low Risk Myelodysplastic Syndrome (MDS) to Reduce the Need for Blood Transfusions
- Model of Saunthararajah et al for Identifying a Patient with Myelodysplastic Syndrome Who Is Likely to Respond to Immunosuppressive Therapy
- Prognostic Score of Malcovati et al for the Myelodysplastic Syndrome Using the WHO Classification (WHO Classification-Based Prognostic Scoring System, WPSS)
- The Category, Cytology, Cytogenetics (CCC) System of Mandel et al for Classifying Pediatric Myelodysplasia
- Simplified Myelodysplastic Syndrome Risk Score of Kantarjian et al
- Idiopathic Cytopenia of Undetermined Significance (ICUS)
- Minimal Diagnostic Criteria of Valent et al for Myelodysplastic Syndrome (MDS)
- Modified International Prognostic Scoring System (IPSS) of Germing et al That Includes the Serum LDH in a Patient with a Myelodysplastic Syndrome (MDS)
- Myelodysplasia in a Patient with Down's Syndrome
- Prognostic Importance of Absolute Eosinophilia or Basophilia Associated with Myelodysplasia
- Prognostic Score of Garcia-Manero et al for a Patient with Lower Risk Myelodysplastic Syndrome (LR-PSS)
- Myelodysplastic Changes in a Patient with Visceral Leishmaniasis (Kala Azar)
- Myelodysplasia with Marrow Fibrosis
- Prognostic Model of Naqvi et al for a Patient with the Myelodysplastic Syndrome
- Vitamin B12-Responsive Pancytopenia Causing Pseudo-Myelodysplasia
- Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Myeloid Abnormalities Subscore
- Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Monocytic Abnormalities Subscore
- Flow Cytometric Score of Wells et al for the Myelodysplastic Syndrome: Final Score
- Comprehensive Cytogenetic Scoring System of Schanz et al for Primary Myelodysplastic Syndrome or Oligoblastic Acute Myeloid Leukemia
- Simplified MDS Risk Score of Gonzalez-Porras et al
- Prognostic Score of Tong et al for Hypocellular Myelodysplastic Syndrome
- Normal Cellularity for the Bone Marrow Biopsy
- Iron Staining in the Bone Marrow Biopsy
- Reticulin in the Bone Marrow Biopsy
- Hazards Associated with Collection of Bone Marrow from the Sternum
- Differential Diagnosis of Pseudo-Gaucher Cells in the Bone Marrow
- Differential Diagnosis of Sea Blue Histiocytes in the Bone Marrow
- Gelatinous Marrow Transformation (GMT, Serous Fat Atrophy, Starvation Marrow)
- Causes of a Dry Bone Marrow Aspirate
- Criteria of Thiele et al for Grading Myelofibrosis (MF)
- Method of Curtin et al for Estimating the Nucleated Red Blood Cell Count of a Newborn Infant at Birth Based on Histologic Examination of the Placenta
- Prognostic Significance of Nucleated Red Blood Cells (NRBCs) for a Patient in the Intensive Care Unit
- Causes of Increased Numbers of Nucleated Red Blood Cells in a Newborn Infant
- Absolute Nucleated Red Blood Cell Count
- Body Fluid Cell Counts Using a Hemocytometer
- Distinguishing Transudate vs Exudate in Pleural, Pericardial and Peritoneal Fluids
- Distinguishing Urine from Ascitic or Pleural Fluid
- Distinguishing Amniotic Fluid from Urine
- Distinguishing Chylous from Pseudochylous (Chyliform, Cholesterol) Effusions
- Cell Count and Cytocentrifuge Preparation for a Body Fluid
- Prognostic Factors in Systemic Mast Cell Disease
- Score of Travis et al for Predicting Survival in Patients with Systemic Mast Cell Disease
- Consensus Classification for Mastocytosis
- WHO Criteria for Systemic Mastocytosis
- "B" and "C" Findings in Patients with Systemic Mastocytosis
- WHO Criteria for Nonmalignant Variants of Systemic Mastocytosis
- WHO Criteria for Mast Cell Leukemia
- WHO Criteria for Mast Cell Tumor (Mastocytoma)
- WHO Criteria for Cutaneous Mastocytosis, Including Urticaria Pigmentosa
- Clinical and Laboratory Findings in a Patient with a Mast Cell Disorder
- Criteria of Akin et al for Mast Cell Activation Syndrome (MCAS)
- Response Criteria Following Therapy in a Patient with Cutaneous Mastocytosis
- Grading Mastocytosis in the Skin (MIS) Symptoms
- Grading Gastrointestinal Symptoms Associated with Mastocytosis
- Serum Viscosity
- Hematocrit and Whole Blood Viscosity
- Equation of Shohat et al for Whole Blood Viscosity in a Neonate with Polycythemia
- Algorithm of Slap et al for When to Biopsy an Enlarged Peripheral Lymph Node in a Young Patient
- Recommendations for When to Biopsy an Enlarged Lymph Node
- Solbiati Index (L to T Ratio) for the Sonographic Examination of a Lymph Node
- Eggshell Calcification in Hilar and Mediastinal Lymph Nodes
- Tattoo Pigment Lymphadenopathy
- Criteria of Raut et al for a Sentinel Lymph Node
- Infectious Granulomatous Lymphadenitis
- Histiocytic Necrotizing Lymphadenitis (Kikuchi-Fujimoto Disease, KFD)
- Argyrophilic Inclusion Positive and Pocked Erythrocyte Counts
- Sonographic Biometry of Spleen Size in Childhood
- Grades of Hackett for Splenomegaly Based on the Clinical Examination
- Normal Splenic Length in Infants and Children Based on the Study of Rosenberg et al
- Criteria for Hematologic Response to Splenectomy in a Patient with Suspected Sequestration
- Evaluation of a Patient For Residual Splenic Tissue Following Splenectomy
- Evaluation of a Patient with Howell-Jolly Bodies in the Peripheral Blood Smear
- Criteria for Pathologist Review of Peripheral Blood Smears
- Features of a Leukoerythroblastic Reaction
- Evaluation of a Peripheral Blood Smear with Possible Schistocytes
- Indications of Bain for a Clinician to Request an Examination of a Peripheral Blood Smear
- Distinguishing an Echinocyte (Burr Cell) from an Acanthocyte in a Peripheral Blood Smear
- Amorphous Blobs in the Peripheral Blood Smear
- Rouleaux
- Selenoid (Crescent) Bodies Within Erythrocytes
- Criteria of Gulati for Grading Hypersegmentation of Neutrophils in a Peripheral Blood Smear
- Criteria of Gulati for Grading Toxic Vacuoles within Neutrophils
- Criteria of Gulati for Grading Toxic Granulation within Neutrophils
- Criteria of Gulati for Grading the Number of Dohle Bodies within Neutrophils
- Grading the Severity of Schistocytosis
- Appearance of Erythrocytes in Pyropoikilocytosis
- Heinz Bodies in Erythrocytes
- Albumin Smear for Smudge Cells
- Algorithm of Kiss et al for Evaluation of a Patient with Microcytic Anemia for Thalassemia
- Diagnostic Algorithm of Lafferty for Thalassemia
- Genetic Factors of Rund and Rachmilewitz Affecting a Patient with Beta-Thalassemia
- Common Clinical Syndromes in Beta-Thalassemia
- Risk Factors of Lucarelli et al Affecting Outcome for a Patient with Thalassemia Who Has Undergone Bone Marrow Transplantation
- Acquired Thalassemia in Myeloproliferative or Myelodysplastic Disorders
- Anemia of Chronic Disease
- Cardio-Renal Anemia (CRA) Syndrome
- Hepcidin in Anemia of Chronic Disease
- Heart Failure-Associated Anemia
- Prediction Rules of Ludwig for Response to Erythropoietin in a Patient with Cancer and Chronic Anemia
- Criteria for Response for Erythropoietin (Epoetin) in a Cancer Patient
- Evaluating a Patient Who Has Failed to Respond to Erythropoietin
- Predictors of Stenke et al for the Response to Erythropoietin in a Patient with a Myelodysplastic Syndrome
- Pure Red Cell Aplasia Associated with the Use of Recombinant Erythropoietin
- Predictive Factors of Musto et al for a Response to Darbepoetin alpha in a Patient with a Low-to-Intermediate Risk Myelodysplastic Syndrome
- Score of Hellstrom-Lindberg for Predicting Response to Erythropoietin Plus Granulocyte Colony Stimulating Factor in an Anemic Patient with Myelodysplasia
- Evaluation of the Patient with Increased MCV but Normal Serum Folate and Vitamin B12 Levels
- Masked Megaloblastic Anemia
- Failure of Megaloblastic Anemia to Respond to Vitamin Replacement Therapy
- Causes of Drug-Induced Megaloblastosis
- Imerslund-Graesbeck Syndrome (Hereditary Megaloblastic Anemia Type 1)
- Clinical Classes of Glucose-6-Phosphate Dehydrogenase (G6PD) Enzyme Variants
- Risk Factors for Acute Hemolysis in Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency
- Clinical Features of an Acute Hemolytic Episode After Fava Bean Ingestion in a Patient with Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (Favism, Fava Crisis)
- Criteria of the International Agranulocytosis and Aplastic Anemia Study for Agranulocytosis (IAAAS)
- Criteria for the Diagnosis of Drug-Induced Agranulocytosis
- Clinical and Laboratory Features of Cyclic Neutropenia
- Prognostic Factors of Julia et al for a Patient with Drug-Induced Agranulocytosis
- Clinical and Laboratory Features of Drug-Induced Agranulocytosis
- Differential Diagnosis of Neutropenia in an HIV-Infected Patient
- Normal White Blood Cell Count Agranulocytosis
- Implications of Dose and Response to Long-Term Granulocyte Colony Stimulating Factor (G-CSF) in a Patient with Severe Congenital Neutropenia
- Algorithm for Classification of Anemia Based on Red Blood Cell Indices and the Reticulocyte Count
- Classification of Bessman et al for Anemia Based on MCV and RDW
- Classification of Anemia Based on Mechanism
- Risk Factors for Anemia in Patients with HIV Disease
- Diagnostic Approach of Moore and Forney for Anemia in HIV-Infected Patients
- Risk Factors of Bani-Sadr et al for Anemia in a Patient Coinfected with HIV and HCV
- Management of a Patient with Eisenmenger Syndrome and Erythrocytosis
- Clinical Features of Hyperviscosity in Erythrocytosis
- Erythrocytosis (Polycythemia) Associated with Androgens and Steroid Hormones
- Erythrocytosis Following Renal Transplantation (Post-Renal Transplantation Erythrocytosis)
- Risk Factors for Neonatal Polycythemia
- Management Algorithm of Jeevasankar et al for Neonatal Polycythemia
- Secondary Erythrocytosis in Patients Treated with a Tyrosine Kinase Inhibitor (TKI)
- Clinical Findings of Myeloperoxidase Deficiency in Neutrophils
- Clinical Finding of Classic Chronic Granulomatous Disease (CGD) with Pediatric Onset
- Clinical Findings of Chronic Granulomatous Disease (CGD) Diagnosed in the Adult
- Clinical Findings Suggesting a Hereditary Leukocyte Adhesion Deficiency (LAD)
- Conditions Associated with Acquired Defects in Neutrophil Function
- Indications for Evaluating a Patient for Inherited Defects in Macrophage Function (Inherited Susceptibility to Mycobacteria and Salmonella)
- Postural Pseudoanemia
- Differential Diagnosis of Ross et al for Hematologic Disorders in a Patient with a Systemic Vasculitis
- Risk Factors of Hung et al for Anemia Associated with Antiviral Therapy in a Patient with Viral Hepatitis C
- Risk Factors for Bone Marrow Suppression in a Patient Receiving Low Dose Methotrexate
- Indications to Test a Patient for Paroxysmal Nocturnal Hemoglobinuria
- Laboratory Features of the Classic and Hypoplastic PNH Phenotypes
- Red Blood Cell Phenotype Mosaicism in Paroxysmal Nocturnal Hemoglobinuria (RBC Types)
- Laboratory Screening of a Patient with Suspected Paroxysmal Nocturnal Hemoglobinuria
- Prognostic Factors of Socie et al Affecting Survival in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Prognostic Factors of Nishimura et al for a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Signs and Symptoms Associated with Smooth Muscle Dystonia in Paroxysmal Noctural Hemoglobinuria (PNH)
- Distinguishing Classic Paroxysmal Nocturnal Hemoglobinuria (PNH) from Aplastic Anemia
- Hemolytic Anemia Following Heavy Alcohol Use (Zieve Syndrome)
- Microangiopathic Hemolytic Anemia
- Criteria of Ruutu et al for Hematopoietic Stem Cell Transplant-Associated Microangiopathy
- Risk Factors for Hematopoietic Stem Cell Transplant-Associated Microangiopathy (TAM)
- Spur Cell Anemia in a Patient with Liver Disease
- Criteria of Ho et al for Transplant-Associated Thrombotic Microangiopathy (TA-TMA, BMT-CTN Criteria)
- Passenger Lymphocyte Syndrome (PLS) with Immune Hemolytic Anemia (Humeral Graft-vs-Host Reaction) in a Transplant Recipient
- Intravascular Hemolysis Secondary to Acute Pancreatitis
- Conditions Associated with Benign Nonhepatosplenic Extramedullary Hematopoiesis
- Clinical Findings Associated with Benign Nonhepatosplenic Extramedullary Hematopoiesis
- Clinical and Pathologic Findings in Pulmonary Extramedullary Hematopoiesis
- Causes of Splenosis
- Locations and Distribution of Splenic Tissue in Splenosis
- Locations for an Accessory Spleen
- Classification of Losanoff et al for Nonparasitic Splenic Cysts
- Classification of Morgenstern for Nonparasitic Splenic Cysts
- Criteria of Morgenstern for Nonoperative Management of a Nonparasitic Splenic Cyst
- Causes of Nontraumatic Rupture of the Spleen
- Criteria for the Diagnosis of Spontaneous Splenic Rupture
- Clinical Features of a Ruptured Spleen
- Risk Factors for Complications Associated with a Splenic Aspirate
- Factors Affecting the Likelihood That a Splenic Aspirate Will Provide Useful Information
- Diagnosis of Hypersplenism
- The Wandering and Pelvic Spleen
- Pleural Splenosis (Thoracic Splenosis)
- Clinical Findings in a Patient with the Hypereosinophilic Syndrome
- Criteria for the Diagnosis of Chronic Eosinophilic Leukemia (CEL)
- Criteria for the Diagnosis of Idiopathic Hypereosinophilic Syndrome (HES)
- Tropical Eosinophilia (Tropical Pulmonary Eosinophilia)
- Differential Diagnosis of Eosinophilia
- Anemia of Prematurity
- Microcytic Anemia Associated with Aluminum Poisoning
- Hemolytic Anemia Associated with Lead Poisoning
- Peripheral Blood Findings in Hemoglobin CC (Spherocytes and Target Cells)
- Clinical and Laboratory Features of Hemoglobin SOarab
- Hereditary Persistence of Hemoglobin F (HPHF)
- Evaluation of a Patient with Hemoglobin S and Elevated Hemoglobin F
- Paraneoplastic Production of Hemoglobin F
- Microcytosis Associated with Hemoglobin E Trait
- Thymic Hyperplasia (Thymic Rebound) Causing a False Positive PET Scan Following Chemotherapy
- Differential Diagnosis of an Elevated Mean Corpuscular Hemoglobin Concentration (MCHC)
- Impact of Plasma Osmolality on the Spun Hematocrit
- Pseudothrombocytopenia Due to a Platelet Cold Agglutinin
- Revised International Prognostic Scoring System (IPSS-R) of Greenberg et al
- Prognostic Score of Itzykson et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
- Prognostic Score of Itzykson et al for a Patient with Higher Risk Myelodysplasia Treated with Azacitidine
- Ring Sideroblasts of Sideroblastic Anemia
- Luetic Lymphadenitis (Syphilitic Lymphadenopathy)
- Clues to Sideroblastic Anemia in the Peripheral Blood Smear
- Algorithm of Mogensen et al for Diagnosing Anemia in a Small Child in an Area of Rural Tanzania Endemic for Malaria
- Differential Diagnosis of Microcytic Anemia
- Chuvash Polycythemia
- Somatic Mutations of Bejar et al Associated with Poor Outcome for a Patient with the Myelodysplastic Syndrome Undergoing Hematopoietic Stem Cell Transplantation
- Normalizing Splenic Volume for Weight and Body Surface Area
- Basophilic Stippling
- Agranular and Hypogranular Platelets
- Anemia of Infection
- Differential Diagnosis of Anemia in a Patient with Infection
- Thiamine-Responsive Megaloblastic Anemia (TRMA) with Diabetes Mellitus and Sensorineural Deafness Associated with Mutations in SLC19A2
- Neonatal Alloimmune Neutropenia (NAIN, Isoimmune Neonatal Neutropenia)
- Clozapine-Associated Neutropenia and Agranulocytosis
- Differential Diagnosis of Neutropenia in a Neonate
- Neonatal Neutropenia Secondary to Maternal Pregnancy-Induced Hypertension
- Delayed Hemolysis After Parenteral Artesunate Therapy for Malaria (Postartemisinin Delayed Hemolysis, PADH)
- Causes of Sideroblastic Anemia
- Sickle Cell Abdominal Vaso-Occlusive Crisis (Sickle Cell Girdle Syndrome, Sickle Cell Ischemic Colitis)
- Impact of Fatigue on Overall Survival for a Patient with Myelodysplastic Syndrome
- Differential Diagnosis of Granulomas in the Bone Marrow
- Significance of Nucleated Red Blood Cells (Erythroblasts) in the Peripheral Blood Smear of a Patient Who is Critically Ill
- Risk Factors of Teawtrakul et al for Severe Infection in a Patient with Non-Transfusion-Dependent Thalassemia
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Hematologic and Iron Status
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Liver and Gallbladder Status
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Cardiovascular Status
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Comorbid Conditions
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Pediatric Patient
- Disease Severity Scoring System (DSSS) of Cappellini et al for Non-Transfusion-Dependent Thalassemia (NTDT): Total Score
- Algorithm of Gibson and Berliner for Evaluating an Adult with Neutropenia
- Sarcoidosis of the Bone Marrow
- Categories of de Latour for a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Equation of Chandra et al for Distinguishing Beta-Thalassemia Minor from Iron Deficiency Anemia
- Impact of Smoking on Hemoglobin Concentrations from the World Health Organization (WHO)
- Risk Assessment Tool of Bernard et al for a Patient with Sickle Cell Disease in the Emergency Department
- Score of Glassberg et al for Predicting 30-Day ED Revisit for Pain in a Patient with Sickle Cell Anemia
- Prognostic Score of Shaffer et al for a Patient with Myelodysplasia Undergoing an Allogeneic Hematopoietic Cell Transplant
- Therapy-Related Myelodysplastic Prognostic Scoring System of Quintas-Cardama et al
- Flow Cytometry Score of Ahlan et al for a Patient with Myelodysplastic Syndrome (MDS)
- Equation of de Simone et al for Whole Blood Viscosity (WBV)
- World Health Organization (WHO) Classification of Anemia Severity Based on Hemoglobin
- Risk Factors of Brodsky et al for 30-Day Readmission for an Adult with Sickle Cell Disease and Vaso-Occlusive Pain
- Criteria of Abou-Elhamd for the Laboratory Diagnosis of Sickle Cell Disease
- Score of Bartolucci et al for Predicting the Acute Chest Syndrome During a Sickle Cell Vaso-Occlusive Crisis
- 2014 Recommendations of the NHLBI Expert Panel for Starting and Continuing Hydroxyurea Therapy in a Patient with Sickle Cell Anemia (SCA)
- Anemia of Thermal Injury (Anemia of Burns)
- Indication for a Bone Marrow Trephine Biopsy
- Adequacy of a Bone Marrow Biopsy in a Pediatric Patient
- Criteria of Hartung et al for Response to Therapy in a Pediatric Patient with Acquired Aplastic Anemia
- Mahidol Score of Sripichai et al for beta-Thalassemia/Hemoglobin E Disease
- Phenotype Score of Phadke and Agarwal for Thalassemia Intermedia
- Criteria of Weatherall for Non-Transfusion-Dependent (NTD) Thalassemia
- Congenital Dyserythropoietic Anemia Type I (CDAI)
- Congenital Dyserythropoietic Anemia Type II (CDA II, HEMPAS)
- Congenital Dyserythropoietic Anemia Type III (CDA III)
- Congenital Dyserythropoietic Anemia Type IV (CDA IV)
- GATA-1 X-Linked Thrombocytopenia With or Without Dyserythropoietic Anemia (XLTDA)
- False Positive and False Negative Diagnosis of Anemia
- Extramedullary Hematopoiesis as Tumor Mass
- AAPT Criteria for the Diagnosis of Chronic Sickle Cell Disease Pain
- Model of Chaturvedi et al for Sickle Cell Disease Based on FEV1 and Tricuspid Regurgitant Jet Velocity
- Differential Diagnosis of Absolute Lymphocytopenia (Lymphopenia)
- Differential Diagnosis of Absolute Lymphocytosis
- Screening Criteria of Andrews et al for Lymphocytosis with an Abnormal Immunophenotype
- Persistent Polyclonal B-Cell Lymphocytosis (PPBL)
- Warning Signs for a Hematologic Malignancy in a Patient with an Unexplained Leukocytosis
- Differential Diagnosis of Absolute Basophilia
- Risk Factors of Poesen et al for Anemia in the First Three Months After a Renal Transplant
- Risk Factors of Butwick et al for Postpartum Anemia After Cesarean Section
- Time to Reversal of Anemia After Blood Donation (Time to Hemoglobin Recovery in a Blood Donor)
- Transient Erythroblastopenia of Childhood (TEC)
- Correction of Hemoglobin Concentrations for Altitude from the World Health Organization (WHO)
- Causes of Stomatocytosis
- Clinical and Laboratory Severity of Hereditary Spherocytosis
- When to Suspect Hereditary Spherocytosis in a Child or Adult
- Diagnosis of Hereditary Spherocytosis in a Neonate
- Dehydrated Hereditary Stomatocytosis (Hereditary Xerocytosis)
- Conditions Associated with Acanthocytes (Spur Cell Anemia, Neuroacanthocytosis)
- Conditions Associated with Echinocytes (Burr Cells)
- Overhydrated Hereditary Stomatocytosis
- Rh Deficiency Syndrome (Rh Null and Rh Mod)
- Eosin-5'-Maleimide (E5M) Flow Cytometry in Hereditary Spherocytosis
- Mean Platelet Volume (MPV) and Prognosis for a Patient with Severe Infection
- Risk Factors for Rapid Progression of Myelodysplasia (MDS) in a Patient with "Low Risk" IPSS
- Refractory Cytopenia of Childhood (RCC)
- Subtypes of Unclassifiable Myelodyplasia (MDS-U)
- Volume of a Trephine Needle Core Bone Marrow Biopsy
- Bone Marrow Edema
- Bone Marrow Score of Wang et al for Identifying an Immunocompetent Patient with Fever of Unknown Origin (FUO) Who Should Have Bone Marrow Biopsy
- Benign Signet Ring Histiocytes in Lymph Node Sinuses
- Hematologic Features of delta-beta-Thalassemia Versus beta-Thalassemia and Iron Deficiency Anemia
- Algorithm of Planche et al for Evaluating a Patient with Extreme Macrocytosis
- Clinical and Laboratory Features of Red Cell Pyruvate Kinase Deficiency
- Indications of Grace et al for Diagnostic Testing in a Patient with Suspected Red Cell Pyruvate Kinase Deficiency
- Predictors of Grace et al for the Response to Splenectomy in a Patient with Red Cell Pyruvate Kinase Deficiency
- Triggers for Hemolysis in Red Cell Pyruvate Kinase Deficiency
- Anemia and Hypophosphatemia
- Criteria of Jodele et al for Hematopoietic Stem Cell Transplant (HSCT) Associated Thrombotic Microangiopathy (TMA)
- Hemolytic Anemia in Wilson's Disease
- Polysplenia Syndrome (Polysplenic Heterotaxy Syndrome)
- Lymphocyte-Variant Hypereosinophilia
- Prognostic Factors of Lefebvre et al for a Patient with Hypereosinophilia
- Paraneoplastic Eosinophilia
- Pediatric Thymic Hyperplasia
- Thymic Hyperplasia and Graves' Disease (Thyrotoxicosis) With or Without Myopathy (Pseudo-Myasthenia Gravis)
- Thymic Index of Hasselbalch et al
- Equation of Hassalbalch et al for Predicting the Thymic Index of a Preterm Neonate
- Equations of Hasselbalch et al for Estimating the Thymic Index in Infants
- Conditions Associated with Eryoptosis
- Differential Diagnosis of Noncaseating Granulomas
- Mayo Score for Chronic Myelomonocytic Leukemia (CMML)
- Adequacy of a Bone Marrow Collection in an Adult
- Equations of Chow et al for Normal Values of Splenic Size
- Erythropoietin Resistance Index (ERI, Erythropoiesis Stimulating Agent Resistance Index)
- Risk Factors of de Lurdes Agostinho Cabrita et al for Erythropoiesis Stimulating Agent Resistance in Pre-Dialysis Chronic Kidney Disease
- Cystatin C and Cardiovascular Dysfunction in Sickle Cell Disease
- Modified WPSS (WHO Classification-Based Prognostic Scoring System) of Cermak et al
- Model of Boutault et al to Screen for Myelodysplastic Syndrome in a Patient with Unexplained Cytopenia (MDS-CBC Score)
- Criteria of Savona et al for Progression in Adult MDS/MPN
- Transfusion Dependence in Myelodysplasia
- Benign Mesothelial Cells in a Lymph Node (Mesothelial Lymph Node Inclusion)
- Blood Smear Changes in Cryoglobulinemia
- Causes of Anemia After Roux-en-Y Gastric Bypass Surgery
- Autoimmune Myelofibrosis (AIMF)
- Hemolytic Anemia Associated a Prosthetic Heart Valve
- Differential Diagnosis of Microangiopathic Hemolytic Anemia Associated with Pregnancy
- Unexplained Hematologic Disorders of the Elderly: Differential Diagnosis
- Unexplained Hematologic Disorders of the Elderly: Idiopathic Cytopenia of Unknown Significance (ICUS)
- Unexplained Hematologic Disorders of the Elderly: Clonal Cytopenia of Unknown Significance (CCUS)
- Unexplained Hematologic Disorders of the Elderly: Idiopathic Dysplasia of Unknown Significance (IDUS)
- Unexplained Hematologic Disorders of the Elderly: Clonal Hematopoiesis of Indeterminate Potential (CHIP)
- Iron Deficiency Anemia Associated with Hereditary Hemorrhagic Telangiectasia (HHT)
- Absolute Reticulocyte Count and the Differential Diagnosis of Pancytopenia
- Differential Diagnosis of DeZern and Guinan for Pancytopenia in a Young Adult
- Algorithm of Naessens et al for the Management of Hemoglobin SC Disease
- Complications of Hemoglobin SC Disease
- Predictive Factors of Silva et al for Adverse Outcomes in a Child with Sickle Cell Disease
- Risk Factors of Belisario et al for Intracerebral Changes in a Neonate with Sickle Cell Anemia
- Markers of Brousse et al for Disease Severity in Infants with Sickle Cell Anemia
- Hypoxia Associated with Right-to-Left Shunt in a Patient with Sickle Cell Anemia
- Cardiac Abnormalities in a Patient with Sickle Cell Anemia
- Vascular High-Risk Profile of Nouraie et al in a Patient with Sickle Cell Anemia
- Cerebral Fat Emboli (CFE) in Patients with Sickle Cell Disease
- Clinical Findings Associated with the Acute Chest Syndrome Associated with Sickle Cell Disease
- Precipitating Factors for the Acute Chest Syndrome in a Patient with Sickle Cell Disease
- Findings of Alkindi et al in a Patient with Sickle Cell Disease That Are Associated with Acute Chest Syndrome (ACS)
- Hereditary Spherocytosis and the MCHC-to-MCV Ratio (Neonatal HS Index)
- Conditions Associated with Decreased Eryoptosis
- Marked Lymphocytosis Associated with Cytomegalovirus (CMV) Infection
- Prognostic Significance of Monocytosis in Myelodysplasia
- Prognostic Score of Liu et al for Unclassifiable Myelodysplastic Syndrome
- Prognostic Factors of Germing et al for a Patient with Chronic Myelomonocytic Leukemia (CMML)
- Prognostic Score of Gonzalez-Medina et al for Chronic Myelomonocytic Leukemia (CMML)
- Cytogenetic Risk Stratification of Such et al for Chronic Myelomonocytic Leukemia (CMML)
- Chronic Myelomonocytic Leukemia (CMML) Specific Prognostic Scoring System (CPSS) of Such et al
- Chronic Myelomonocytic Leukemia Specific Prognostic Scoring System of Elena et al (CMML CPSS-mol)
- Bedside Risk Categories of Tefferi et al for a Patient with a Myelodysplastic Syndrome (MDS)
- MastFx Score of van der Veer et al for Predicting Fragility Fractures Associated with Indolent Systemic Mastocytosis (ISM)
- Anaphylaxis Risk Assessment Tool of Gulen et al for a Patient with Systemic Mastocytosis
- NIH Idiopathic Clonal Anaphylaxis Score (NICAS) of Carter et al
- Equation of Prassopoulos et al for Splenic Volume in Adults
- Pappenheimer Bodies
- Target Cells (Codocytes)
- Cabot Rings
- Teardrop Cells (Dacrocytes)
- Leptocytes (Wafer Cells)
- Bite Cells
- Blister Cell
- Neutrophilic Changes Associated with Bacterial Infection
- Anemia Associated with Scurvy
- ITACA Score of Buckstein et al for Response to an Erythropoietic Stimulating Agent in a Patient with Myelodysplasia
- Differential Diagnosis of Neutropenia Associated with Infectious Mononucleosis
- Neutropenia Associated with Large Granular Lymphyocytes
- Differential Diagnosis of a Macrocytic or Megaloblastic Anemia
- Differential Diagnosis of Normocytic Anemia
- Causes of Hemolytic Anemia
- Differential Diagnosis of Hemolytic Anemia in a Neonate
- Conditions Associated with Splenic Infarction
- Algorithm of Patnaik and Tefferi for Evaluating a Patient with Ring Sideroblasts
- Differential Diagnosis of Congenital Sideroblastic Anemia
- Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (RARS-T, Myelodysplastic/Myeloproliferative Neoplasm with Ringed Sideroblasts and Thrombocytosis, MDS/MPN-RS-T)
- Prognostic Score of Patnaik et al for Refractory Anemia with Ringed Sideroblasts and Thrombocytosis (RARS-T, Myelodysplastic/Myeloproliferative Neoplasm with Ringed Sideroblasts and Thrombocytosis, MDS/MPN-RS-T)
- Equation of Matos et al for Distinguishing Iron Deficiency Anemia from Thalassemia Trait (Matos and Carvalho Index)
- RDW Index (RDWI) of Jaybose et al for Differentiating Iron Deficiency Anemia from Thalassemia Trait
- Index of Ehsani et al for Discrimination Between Iron Deficiency Anemia and Beta-Thalassemia Minor
- Equation of Sirdah et al for Distinguishing Iron Deficiency Anemia from Beta Thalassemia Minor
- Pancytopenia Associated with Severe Anorexia Nervosa
- Mean Platelet Volume (MPV) to Lymphocyte Ratio (MPVLR)
- Mean Platelet Volume to Platelet Count Ratio (MPV to PC Ratio)
- Ratio of Platelet Distribution Width (PDW) to Platelet Count
- White Blood Cell Count to Mean Platelet Volume (MPV) Ratio (WMR)
- Leukemoid Reaction
- Predictors of Nomdedeu et al for Excess Mortality in a Patient with Myelodysplastic Syndrome
- Risk Score of Shi et al for a Patient with Myelodysplasia
- Clinical Prognostic Score of Starkman et al for a Patient with the Myelodysplastic Syndrome (MDS)
- Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Transfusion-Dependent Thalassemia (TDT)
- Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Transfusion-Dependent Thalassemia (NTDT) Patients Receiving Transfusions
- Complication Risk Scores of Vitrano et al for a Patient with Thalassemia: Non-Transfusion-Dependent Thalassemia (NTDT) Not Receiving Transfusion
- Screening Criteria of Samavat for Beta-Thalassemia Minor
- Model of Santini et al for Predicting Response to Erythropoietic-Stimulating Agents with IPSS Low or Intermediate-1 Risk Myelodysplasia
- Congenital Neutropenia Due to G3PC3 Deficiency Including Dursun Syndrome
- Hemogram Pattern Associated with a Cold Agglutinin
- Anemia Associated with Cadmium Intoxication
- CT Grading Scale of McCune et al for Thymic Size
- X-Linked Sideroblastic Anemia and Cerebellar Ataxia (XLSA/A) Associated with Mutations in ABC7 (ABCB7)
- X-Linked Sideroblastic Anemia Associated with Mutations in ALAS2
- Myopathy, Lactic Acidosis and Sideroblastic Anemia (MLASA)
- Congenital Sideroblastic Anemia Associated with Mutations in GLRX5
- Congenital X-Linked Sideroblastic Anemia Associated with Mutations in NDUFB11
- Congenital Sideroblastic Anemia Associated with Mutations in SLC25A38
- Phenotypic Risk Score of Sachdev et al for Predicting Mortality in Sickle Cell Disease (PReMSCD)
- Biomarkers of Nouraie et al for Risk of Mortality for a Young Patient with Sickle Cell Disease
- Growth Failure in a Patient with Sickle Cell Anemia
- Fat Embolism Syndrome in Sickle Cell Disease
- Predictors of Kumar et al for 30-Day Readmission Following a Sickle Cell Crisis
- Idiopathic CD4+ Lymphocytopenia (ICL)
- M.D. Anderson Lower-Risk Prognostic Scoring System (LR-PSS, LR-MDAS) for a Patient with Myelodysplasia
- Myelodysplastic Syndrome Associated with Mutations in SF3B1
- Mutation-Augmented Prognostic Scoring System (MAPSS) of Pardanani et al for Advanced Systemic Mastocytosis
- REMA Score of Alvarez-Twose et al for Systemic Mast Cell Activation Disorder (MCAD)
- Jordans' Anomaly (Cytoplasmic Lipid Droplets in Granulocytes)
- Thyrotoxicosis-Induced Anemia
- Anemia in Crohn's Disease
- Differential Diagnosis of Severe Congenital Neutropenia (SCN)
- Investigation of Neutropenia in a Patient with Neutropenia
- Rules of Yefet et al for Avoiding Iron Deficiency Anemia in a Pregnant Woman at the Time of Delivery
- Anemia Associated with Geophagia and Other Forms of Pica
- Index of Brewin et al for Ineffective Erythropoiesis (IoIE) in Sickle Cell Disease
- Extreme Hyperbilirubinemia in Sickle Cell Disease
- Red Flags of Cisewski for Evaluating a Patient with Sickle Cell Disease in the Emergency Department
- Brown Fat in the Bone Marrow
- Predictors of Simsek for Mortality After Non-Traumatic Splenectomy
- Prognostic Score of Khirallah et al for a Pediatric Patient Undergoing Splenectomy for a Benign Hematological Disorder
- Grading Score of Luppi et al for Technical Difficulty of a Laparoscopic Splenectomy for a Non-Traumatic Disorder (Difficulty Score)
- Score of Liu et al for Predicting Difficulty of Laparoscopic Splenectomy for a Non-Traumatic Disease
- Predictive Factors of Nyilas et al for Laparoscopic Splenectomy for Immune Thrombocytopenic Purpura (ITP)
- Partial Splenectomy
- Screening Criteria of Ambayya et al to Distinguish Between Alpha and Beta Thalassemia Traits
- Predictors of Kamperidis et al for Long-Term Survival in a Transfusion-Dependent Patient with Thalassemia
- Score of Xu et al for a Patient with Aplastic Anemia Following a Haploidentical Allogeneic Hematopoietic Stem Cell Transplant (Haplo-HSCT Scoring System)
- The Sickling Hemoglobinopathies
- Mast Cell Activation Syndrome (MCAS) in a Patient with Sickle Cell Disease
- Barriers to the Use of Hydroxyurea in a Pediatric Patient with Sickle Cell Anemia
- Impact of HIV on the Prognosis of Myelodysplastic Syndrome (MDS)
- Risk Stratification Score of Hou et al for a Patient with the Myelodysplastic Syndrome
- Benign Ethnic Neutropenia (BEN)
- Autoimmune Neutropenia
- Childhood Neutropenia in PAMI
- Genetic Causes of Chronic Granulomatous Disease (CGD)
- Differential Diagnosis of Anemia in Chronic Granulomatous Disease (CGD)
- Hemophagocytic Lymphohistiocytosis (HLH) Reactions in Chronic Granulomatous Disease (CGD)
- Prognostic Factors of Virk et al for a Patient with Spur Cell Hemolytic Anemia (SCHA) Associated with End-Stage Liver Disease
- Splenic Peliosis
- Splenic Torsion and the Wandering Spleen
- CT Manifestations of Splenic Torsion
- Unstable Hemoglobinopathies (Congenital Heinz Body Hemolytic Anemia)
- Congenital Methemoglobinemia
- Equations of Xiao et al for Distinguishing Thalassemia Traits from Iron Deficiency Anemia in a Pregnant Woman
- Pancytopenia Associated with Cannabis Use
- Pancytopenia in a Patient with Graves' Disease
- Pancytopenia with Myelodysplastic Features in Chronic Arsenic Poisoning
- Features of Iwasaki et al for Distinguishing Aplastic Anemia from Myelodysplastic Syndrome
- Predictors of Zaimoku et al for Response of a Patient with Aplastic Anemia to Therapy
- Score of Olupot-Olupot et al for Screening a Sick Child in Africa for Sickle Cell Anemia
- Nutritional Indices in Patients with the Myelodysplastic Syndrome
- Genomic Groups of Bersanelli et al for Myelodysplastic Syndromes
- Prognostic Significance of Hemoglobin F in Patients with Myelodysplastic Syndrome
- CMML Transplant Score of Gagelmann et al for a Patient with CMML
- Chronic Myelomonocytic Leukemia (CMML) Variants
- Prognostic Score of Patnaik et al for a Patient in CMML
- Use of Serum Ferritin and Age to Evaluation a Patient with Transfusion-Dependent Thalassemia for Iron Overload
- Thalassemia International Prognostic Scoring System (TIPSS)
- Grading Myocardial Iron Overload (MIO) in Transfusion-Dependent Thalassemia
- Grading Hepatic Iron Overload (HIO) in Transfusion-Dependent Thalassemia
- Equations of Hayreh et al for Estimating the Upper Limit of Normal for the Erythrocyte Sedimentation Rate (ESR)
- Equation of Sirachainan et al for Differentiating Thalassemia Trait from Iron Deficiency Anemia
- Iron Deficiency Anemia in Inflammatory Bowel Disease (IBD, Crohn's Disease, Ulcerative Colitis)
- Early Death Risk Score Model of Liu et al for a Patient with Severe Aplastic Anemia
- Factitious Aplastic Anemia
- Index of Ineffective Erythropoiesis (IoIE)) as Measure of Ineffective Erythropoiesis in Sickle Cell Disease
- Prognostic Factors of Qian et al for a Patient with Myelodysplasia
- Pseudoreticulocytosis (Delayed Maturation of Reticulocytes) in Myelodysplasia
- Study of Musallam et al for Predicting Survival of a Patient with Non-Transfusion Dependent Beta Thalassemia
- Decisions in Erythropoietin Therapy in a Patient with Cancer
- Hemolysis Associated with Fresh Water Near-Drowning (Drowning Hemoglobinuria)
- Thal Index of Nishad et al
- Equation of Bordbar et al for Distinguishing Beta-Thalassemia Minor from Other Microcytic Anemias
- Model of Xu et al for Distinguishing Thalassemia Trait from Iron Deficiency Anemia
- Hemoconcentration and Increase in Hematocrit
- Predictors of Groarke et al for Clonal Evolution in a Patient with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
- Spontaneous Subgaleal Hematoma in a Patient with Sickle Cell Disease (Acute Soft Head Syndrome)
- Mutated Gene Count of Nazha et al for a Patient with Myelodysplasia
- Flow Cytometric (FCM) Score of Della Porta et al for the Diagnosis of Low-Grade Myelodysplasia
- Myelodysplasia Cutis
- Mutation Risk Score and the MIPSS-R of Gu et al for Risk Stratification of a Patient with Myelodysplasia
- RED Score of Mathis et al for Diagnosis of Myelodysplasia By Flow Cytometry
- Nomogram of Liang et al for Evaluating a Patient with Myelodysplastic Syndrome (MDS)